logo

For the Inventor, By the Inventor

Minoo, Japan

Akira Matsumori

This inventor holds 12 USPTO granted patents. Top assignees: Otsuka Pharmaceutical Company, Limited, Toray Industries, Inc., Akira Matsumori. Active years: 1996-2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Akira Matsumori. Retrieved from https://idiyas.com/inventor/akira-matsumori

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 12

% Patents Active = 58.3

Average Co-Inventor Count = 1.1

ph-index = 3

Forward Citations = 79(Granted Patents)


Location History:

  • Mino-shi, Osaka JP (1996)
  • Osaka, JP (2001)
  • Mino, JP (2004)
  • Minoh-shi, Osaka, JP (1996 - 2010)
  • Minoo, JP (1998 - 2011)
  • Minoh, JP (2011 - 2020)

Company Filing History:

goldMedal3 out of 846 
 
Otsuka Pharmaceutical Company, Limited
 patents
silverMedal2 out of 3,586 
 
Toray Industries, Inc.
 patents
bronzeMedal1 out of 1 
 
Akira Matsumori
 patent
4. 1 out of 23 
 
Daiichi Suntory Pharma Co., Ltd.
 patents
5. 1 out of 263 
 
Mitsubishi Tanabe Pharma Corporation
 patents
6. 7 out of 834,570 
Other
 patents
where one patent can have more than one assignee

Years Active: 1996-2020

Loading Chart...
12 patents (USPTO):Explore Patents
1. 10823741 - Method for detecting cardiac failure patient (2020-11-03),
2. 7989174 - Biomarker for diagnosing heart disease and the use thereof (2011-08-02),
3. 7968549 - Diarylmethylpiperazines as therapeutic agents for viral myocarditis (2011-06-28),
4. 7902261 - Medicinal compositions for preventing or treating viral myocarditis (2011-03-08),
5. 7781178 - Biomarker for diagnosing heart disease and the use thereof (2010-08-24),
6. 6710046 - Pharmaceutical composition for modulating immunity (2004-03-23),
7. 6703421 - Methods of using phenylmethylbenzoquinone and hydroquinone compounds for treatment of myocarditis, dilated cardiomyopathy and heart failure (2004-03-09),
8. 6695788 - Methods for measurement of hemodynamics (2004-02-24),
9. 6214535 - Method for testing cardiac myocarditis or cardiomyopathy (2001-04-10),
10. 5827673 - Method of detecting myocardial infarction (1998-10-27),
11. 5545623 - Method of inhibiting secretion of inflammatory cytokines (1996-08-13),
12. 5521185 - Methods for inhibiting graft rejection and IL-1 production (1996-05-28),

Title: Akira Matsumori: Innovator in Cardiac Health

Introduction

Akira Matsumori is a prominent inventor based in Minoo, Japan. He has made significant contributions to the field of cardiac health, holding a total of 12 patents. His innovative methods aim to improve the diagnosis and management of heart diseases.

Latest Patents

Matsumori's latest patents include a groundbreaking method for detecting cardiac failure patients. This method involves measuring the value of CKAP4 in a blood sample collected from a subject. The measured value is then compared with a predetermined standard value. If the measured value of CKAP4 is lower than the standard, the subject is determined to be a cardiac failure patient. Another notable invention is a biomarker for diagnosing heart disease, which includes various methods and a kit for implementation.

Career Highlights

Throughout his career, Matsumori has worked with notable companies, including Otsuka Pharmaceutical Company, Limited. His work has focused on advancing medical technologies that enhance patient care and outcomes in cardiac health.

Collaborations

Matsumori has collaborated with esteemed colleagues such as Ryosuke Nishio and Yoichi Nunokawa. Their combined expertise has contributed to the development of innovative solutions in the medical field.

Conclusion

Akira Matsumori's contributions to cardiac health through his patents and collaborations highlight his dedication to improving patient outcomes. His innovative methods continue to pave the way for advancements in the diagnosis and treatment of heart diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…